Skip to content

News Releases

 
News Releases
  Date Title and Summary View
Jun 21, 2001
WHAT: Thousands of pounds of zesty barbecue, three music stages one each for blues, jazz and rock 'n roll, the Pepcid Complete Hot Seat and 80,000+ visitors will be cheek to jowl on Pennsylvania Avenue, from 9th to 13th Streets for the 9th Annual Nation...
Jun 20, 2001
NEW BRUNSWICK, N.J., and MOUNTAIN VIEW, Calif., Jun 20, 2001 -- Johnson & Johnson (NYSE: JNJ) and ALZA Corporation (NYSE: AZA) today announced that subject to the approval of ALZA stockholders at a special meeting on June 21, 2001, the proposed merger is anticipated to close on Friday June 22, 2001. The ALZA stockholder meeting is scheduled for 9:3...
May 25, 2001
NEW BRUNSWICK, N.J., May 25 -- Johnson & Johnson will host a pharmaceutical business and research & development review with analysts beginning at 8:30 a.m. (PDT) on Wednesday, May 30, 2001 in La Jolla, California. William C. Weldon, Vice Chairman of Johnson & Johnson and member of the Executive Committee, will be hosting the event. A schedule of th...
May 23, 2001
NEW BRUNSWICK, N.J., and WALTHAM, Mass., May 23 -- Johnson & Johnson (NYSE: JNJ), the world's most comprehensive and broadly based manufacturer of health care products, and Inverness Medical Technology (Amex: IMA), a developer of innovative products focused primarily on the self-management of diabetes, today announced they have entered into a defin...
May 22, 2001
FORT WASHINGTON, Pa., May 22 -- Take this job and switch it is the rallying cry for Pepcid Complete, the first and only dual action heartburn remedy. The brand is calling for entrants who want to become critics of some of the finest restaurants in the U.S. as part of its "Make the Pepcid Complete Switch Sweepstakes" online advertising campaign and ...
May 21, 2001
Maintenance treatment with the drug REMICADE®(infliximab) can sustain remission-level control of the symptoms of Crohn's disease and eliminate the need for steroid use, according to data presented May 21 from the University of Chicago Medical Center during this year's Digestive Disease Week meeting. Get video here. You can reach the s...
May 21, 2001
ATLANTA, May 21 -- It is estimated that Americans will spend $10 billion this year on prescriptions for Proton Pump Inhibitors (PPIs). However, a new study being presented today at Digestive Disease Week shows that 40% of GERD (Gastroesophageal Reflux Disease) patients taking a single dose of the most popular PPI, Prilosec®, experience breakthr...
May 10, 2001
NEW BRUNSWICK, N.J., and MOUNTAIN VIEW, Calif., May 10 -- Johnson & Johnson (NYSE: JNJ) and ALZA Corporation (NYSE: AZA) today announced the early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvement Act with respect to the acquisition of ALZA by Johnson & Johnson. ALZA Corporation, headquartered in Mountain View...
May 9, 2001
NEW BRUNSWICK, N.J. and WALTHAM, Mass., May 9 -- Johnson & Johnson (NYSE: JNJ), the world's most comprehensive and broadly based manufacturer of health care products, and Inverness Medical Technology (Amex: IMA), a developer of innovative products focused primarily on the self-management of diabetes, today announced they are in advanced discussions...
May 3, 2001
NEW BRUNSWICK, N.J., May 3 -- Johnson & Johnson will participate in The Deutsche Banc Alex. Brown Inc., 2001 Health Care Conference at the Baltimore Marriott Waterfront Hotel on May 9, 2001 at 3:00 p.m. EST. There will be a formal presentation on Johnson & Johnson by William C. Weldon, Vice Chairman, Board of Directors, and Robert G. Savage, Worldw...
Page: FirstPrevious ...
163
... NextLast
= add release to Briefcase